Company Overview
Representative
Lee Wang -jun, Hwang Do -soon
Company Type
ManuFacturer
Year founded
2001
Event
Medical/Pharmaceutical Industry
Number of employees
50 to 299 people
Annual turnover
More Than Krw 1 Billion ~ Less Than Krw 12 Billion
Address
173, Digital -ro, Geumcheon -gu, Seoul (Gasan -dong)
Representative number
+82-504-1361-0883
Company Introduction
CANCERROP has 2 main business
• IVD Diagnostic Business:
CANCERROP has 3 different types of covid-19 detection IVD product which is RT-PCR, Antibody, Antigen. It has the international authorized certifications with ISO13485, KFDA, CE-IVD, FSC-EU
and it is selling towards the overseas and domestic markets. For the post-coronavirus era, CANCERROP is now preparing for a new pipeline with more diverse products.
• Precision Medicine Service:
CANCERROP has providing the chromosomal testing services based on the NGS(Next Generation Sequencing), Microarray Chip for more than a decades. CANCERROP is leading the market with the outstanding records of the largest volume of testing, related paper listed, the newest equipment facility, and the biggest big data in Korea.
• IVD Diagnostic Business:
CANCERROP has 3 different types of covid-19 detection IVD product which is RT-PCR, Antibody, Antigen. It has the international authorized certifications with ISO13485, KFDA, CE-IVD, FSC-EU
and it is selling towards the overseas and domestic markets. For the post-coronavirus era, CANCERROP is now preparing for a new pipeline with more diverse products.
• Precision Medicine Service:
CANCERROP has providing the chromosomal testing services based on the NGS(Next Generation Sequencing), Microarray Chip for more than a decades. CANCERROP is leading the market with the outstanding records of the largest volume of testing, related paper listed, the newest equipment facility, and the biggest big data in Korea.